C57BL/6N-Atm1Brd Krt8tm1a(EUCOMM)Hmgu/IcsOrl

Status

Available to order

EMMA IDEM:09978
International strain nameC57BL/6N-Atm1Brd Krt8tm1a(EUCOMM)Hmgu/IcsOrl
Alternative nameHEPD0592_4_D04
Strain typeTargeted Mutant Strains
Allele/Transgene symbolKrt8tm1a(EUCOMM)Hmgu
Gene/Transgene symbolKrt8
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider ICS, Institut Clinique de la Souris
Provider affiliationICS, Institut Clinique de la Souris
Genetic informationThis mouse line originates from EUCOMM ES clone HEPD0592_4_D04. For further details on the construction of this clone see the page at the IKMC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivingheterozygous C57BL/6N Tac

Disease and phenotype information

IMPC phenotypes (gene matching)
  • increased neutrophil cell number / IMPC
  • increased prepulse inhibition / IMPC
  • improved glucose tolerance / IMPC
  • decreased exploration in new environment / IMPC
  • preweaning lethality, complete penetrance / IMPC
MGI phenotypes (gene matching)
  • extramedullary hematopoiesis / MGI
  • abnormal intestinal epithelium morphology / MGI
  • rectal prolapse / MGI
  • abnormal colon morphology / MGI
  • abnormal hepatocyte morphology / MGI
  • enlarged spleen / MGI
  • decreased body weight / MGI
  • internal hemorrhage / MGI
  • hepatic necrosis / MGI
  • abnormal intestinal mineral absorption / MGI
  • abnormal placenta morphology / MGI
  • reduced female fertility / MGI
  • female infertility / MGI
  • chronic inflammation / MGI
  • hepatic steatosis / MGI
  • liver hemorrhage / MGI
  • abnormal extraembryonic tissue physiology / MGI
  • abnormal trophoblast layer morphology / MGI
  • abnormal trophoblast giant cell morphology / MGI
  • diarrhea / MGI
  • impaired placental function / MGI
  • decreased embryo weight / MGI
  • embryonic lethality during organogenesis, incomplete penetrance / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).